Position in SYRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$39,991,202
+$15,738,123 QoQ
Shares Held
792,847
+7.1% QoQ
Ownership
0.913%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Polar Capital Holdings Plc holds $3,129,351,296 across 43 Biotechnology names. SYRE ranks #29 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
4,405,312 | $256,168,892 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
5,065,933 | $198,584,573 | |
| 3 | NUVL |
Nuvalent, Inc.
|
1,831,253 | $187,611,869 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
2,519,306 | $187,083,663 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
289,310 | $151,445,105 | |
| 6 | ASND |
Ascendis Pharma A/S
|
651,712 | $149,066,085 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
192,546 | $148,768,741 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,615,586 | $140,507,514 |
All Filings in SYRE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,991,202 | 792,847 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,253,079 | 740,326 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,220,086 | 788,788 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,152,650 | 745,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,311,375 | 825,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,460,000 | 750,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,705,000 | 500,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,755,000 | 500,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,965,000 | 500,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,760,000 | 500,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,675,000 | 300,000 | Shares | Defined | 2023-11-22 | |
| No filing history on record for this holder in this stock. | ||||||